Cargando…
Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium
Human Mesenchymal Stem Cells (hMSCs) present a promising tool for regenerative medicine. However, ex vivo expansion is necessary to obtain sufficient cells for clinical therapy. Conventional growth media usually contain the critical component fetal bovine serum. For clinical use, chemically defined...
Autores principales: | Mark, Peter, Kleinsorge, Mandy, Gaebel, Ralf, Lux, Cornelia A., Toelk, Anita, Pittermann, Erik, David, Robert, Steinhoff, Gustav, Ma, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806428/ https://www.ncbi.nlm.nih.gov/pubmed/24194767 http://dx.doi.org/10.1155/2013/698076 |
Ejemplares similares
-
Angiogenic Potential of Bone Marrow Derived CD133(+) and CD271(+) Intramyocardial Stem Cell Trans- Plantation Post MI
por: Sasse, Sarah, et al.
Publicado: (2019) -
CD271(+) Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
por: Sadraddin, Haval, et al.
Publicado: (2019) -
Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs
por: Schade, Anna, et al.
Publicado: (2014) -
Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
por: Lemcke, Heiko, et al.
Publicado: (2017) -
Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
por: Klopsch, Christian, et al.
Publicado: (2018)